N2 Applied
Biotech solutions company
N2 Applied has raised €14M across 2 funding rounds from 5 investors, most recently a round in Jan 2023. Based in Norway; active in Software and E-commerce. Data as of 29 Oct 2026.
Total raised
€14M
€13,720,831
Funding rounds
2
Investors
5
distinct backers
Active since
2017-05
latest 2023-01
Funding by year
EUR raised per yearN2 Applied — funding by year — interactive chart.
Data table
| N2 Applied — funding by year | |
|---|---|
| 2017 | €3.7M |
| 2023 | €10M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Past typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood9
base rate 11% (2+ rounds)
- ▲ 9y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-01-11 | Other | €10M | Blue River Invest,European Innovation Council (EIC),Holta Invest,NorgesGruppen,Ramussengruppen | View deal → |
| 2017-05-30 | Other | €3.7M | — | View deal → |
Investors
5Related news
Similar companies
same sector, similar size- Chooose€14MNorway · Software
- reMarkable€14MNorway · Software
- Vev€10MNorway · Software
- Memory€16MNorway · Software
- Roboxi€13MNorway · Software
- Kryptovault€15MNorway · Software
Global coverage: FundingData